Abstract: An antenna system is disclosed that provides a directional radiation field. The antenna system includes at least two monopole antennas, each of which provides a differential connector. Each differential connector is associated with a signal having a different phase such that a radiation field associated with said antenna system is other than a radiation field that would exist if each differential connector were associated with the signal having the same phase.
Type:
Grant
Filed:
August 30, 2010
Date of Patent:
March 8, 2016
Assignee:
University of Rhode Island Research Foundation
Abstract: The invention provides novel compositions based on a structure designated as “Honaucin A”, including Honaucin A variants and analogs, and pharmaceutical compositions, liposomes and nanoparticles comprising them, and methods of making and using them. In one embodiment, these Honaucin A compounds, and variants and analogs thereof are used to ameliorate (including to treat or prevent) inflammation. In one embodiment, these Honaucin A compounds, and variants and analogs thereof are used to ameliorate (including to treat or prevent) inflammation. In one embodiment, these Honaucin A compounds, and variants and analogs thereof are used as bacterial quorumsensing inhibitors. Accordingly, in alternative embodiments the compositions of the invention are used as anti-bacterial agents.
Type:
Grant
Filed:
June 3, 2011
Date of Patent:
July 7, 2015
Assignees:
The Regents of the University of California, University of Rhode Island Research Foundation
Inventors:
William Gerwick, Lena Gerwick, Hyuakjae Choi, Francisco Villa, Jennifer Smith, David C Rowley
Abstract: The invention provides novel compositions based on a structure designated as “Honaucin A”, including Honaucin A variants and analogs, and pharmaceutical compositions, liposomes and nanoparticles comprising them, and methods of making and using them. In one embodiment these Honaucin A compounds, and variants and analogs thereof are used to ameliorate (including to treat or prevent) inflammation. In one embodiment, these Honaucin A compounds, and variants and analogs thereof are used to ameliorate (including to treat or prevent) inflammation. In one embodiment, these Honaucin A compounds, and variants and analogs thereof are used as bacterial quorumsensing inhibitors. Accordingly, in alternative embodiments the compositions of the invention are used as anti-bacterial agents.
Type:
Application
Filed:
June 3, 2011
Publication date:
May 29, 2014
Applicants:
UNIVERSITY OF RHODE ISLAND RESEARCH FOUNDATION, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventors:
William Gerwick, Lena Gerwick, Huykjae Choi, Francisco Villa, Jennifer Smith, David C Rowley